Hematology Updates by Xagena

HematologyNews.net

HematologyNews.net :: Hematology

Hematology News, Newsletter :: Hematology, Newsletter Ematologia, Hematology :: Updates,  Aggiornamento in Medicina, AZ Guide in Hematology, Hematology, Haematology, Drugs in Hematology

Carfilzomib

Carfilzomib: no impact of renal function on treatment in …

Brentuximab Vedotin

Long-term follow-up data from Brentuximab Vedotin pivotal …

Blinatumomab

Acute lymphoblastic leukemia treated with bispecific antibody …

4-1BB agonist monoclonal …

4-1BB agonist monoclonal antibodies: PF-05082566 in …

Imbruvica

Chronic lymphocytic leukemia and mantle cell lymphoma …

Volasertib improves overall …

Volasertib improves overall survival in older patients with …

Relapsed chronic lymphocytic …

Relapsed chronic lymphocytic leukemia: Idelalisib in …

Eltrombopag

A double-blind, multicenter, phase III study found that long-term …

Classical Hodgkin lymphoma

Relapsed or refractory Hodgkin lymphoma, Nivolumab has …

Patients with chronic …

Patients with chronic lymphocytic leukemia and coexisting …

Medical News by Xagena

XagenaNewsletter

https://xagenaweb.it/

MedicineNews.net: Drugs –   Medicine News

Newsletter :: Medicine, Aggiornamenti in Medicina, Newsletter :: Medicina, Newsletter :: Medical News, Medicine News, Medicine Newsletter, MedicineNews.net, AZ Guide Medicine, Newsletter Allergology, Newsletter Andrology, Newsletter Cardiology, Newsletter Dermatology, Newsletter Diabetology, Xagena Medical News, Newsletter Hematology, Newsletter Oncology,  
– 

Cimzia

The Food and Drug Administration ( FDA ) has approved Cimzia …

Rivaroxaban

The oral anticoagulant Xarelto ( Rivaroxaban ) has been …

Dapagliflozin

Forxiga ( Dapagliflozin ) is the first SGLT2 ( sodium/glucose …

Sirturo

Treatment for drug-resistant tuberculosis: Sirturo shows …

Teriflunomide

Teriflunomide ( Aubagio ) is an immunomodulatory drug …

Potiga

The FDA ( Food and Drug Administration ) has approved …

Macitentan

The Food and Drug Administration ( FDA ) has approved Opsumit …

Opsumit

The Food and Drug Administration ( FDA ) has approved Opsumit …

Forxiga

Forxiga, a SGLT2 inhibitor, approved in Europe for …

Pertuzumab

Pertuzumab for the treatment of patients with HER2-positive …

Hematology News by Xagena

HematologyNews.net

Hematology – HematologyNews.net

Hematology, HematologyNews.net, Hematology News, Newsletter Hematology, Aggiornamento in Medicina, Aggiornamento in Ematologia, Ematologia News, Hematology :: Therapy :: Newsletter, Terapia ematologica, Farmaci ematologici, Blood Disorders :: Therapy, Hematology Education Program,
– 

Glivec

Risultati ricerca per “Glivec” … Tasigna when Glivec fails in …

Pulmonary embolism

Relapsed or refractory multiple myeloma: clinical benefits with …

Exjade

Exjade: FDA Panel recommends approval for once-daily oral …

Immune thrombocytopenic

Immune thrombocytopenic purpura: AMG 531 increases platelets.

Deferasirox

Risultati ricerca per “Deferasirox” … on the safety of Exjade …

Ibrutinib

BTK inhibitors: Ibrutinib has shown durable efficacy as …

Idelalisib

Idelalisib in combination with Rituximab for older patients with …

Bendamustine

Indolent and mantle-cell lymphomas: Bendamustine plus …

Chronic iron overload

Exjade reduces iron overload in patients with non-transfusion …

Apixaban

Apixaban for the treatment of deep vein thrombosis and pulmonary …